AB, S., E, D., A, C., M, R., A, T., C, L., . . . JL, S. (2024). Genetic and clinical characterization of a novel <i>FH</i> founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome.
Citación estilo ChicagoAB, Sánchez-Heras, et al. Genetic and Clinical Characterization of a Novel <i>FH</i> Founder Mutation in Families With Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome. 2024.
Cita MLAAB, Sánchez-Heras, et al. Genetic and Clinical Characterization of a Novel <i>FH</i> Founder Mutation in Families With Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome. 2024.
Precaución: Estas citas no son 100% exactas.